Impurity reference standards
Pitavastatin impurities & reference standards
Characterised Pitavastatin impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
40reference materials
COAHPLC · NMR · MS on request
![(3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid chemical structure](/media/structures/JEAIZQYPWPSXQH-QRQCRPRQSA-N.svg)
(3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic acid
- CAS
- 1187966-93-3
- Formula
- C25H22FNO4
- MW
- 419.4 g/mol
VQ-027536
(E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3-hydroxy-5-oxohept-6-enoic acid
- CAS
- 1809100-36-4
- Formula
- C25H22FNO4
- MW
- 419.4 g/mol
VQ-033230
(S,E)-5-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3-hydroxypent-4-enoic Acid
- CAS
- 222306-19-6
- Formula
- C23H20FNO3
- MW
- 377.41 g/mol
VQ-041534
(S,E)-6-(2-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-5,6-dihydro-2H-pyran-2-one
- CAS
- 148516-15-8
- Formula
- C25H20FNO2
- MW
- 385.4 g/mol
VQ-033231
(S,E)-6-(2-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)dihydro-2H-pyran-2,4(3H)-dione
- CAS
- 2245811-13-4
- Formula
- C25H20FNO3
- MW
- 401.4 g/mol
VQ-027541
![[2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido chemical structure](/media/structures/NLIQETRDGNRDCT-UHFFFAOYSA-M.svg)
[2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido
- CAS
- 154057-58-6
- Formula
- C37H30BrFNP
- MW
- 618.5 g/mol
VQ-027532
2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methylbromide
- CAS
- 154057-56-4
- Formula
- C19H15BrFN
- MW
- 356.2 g/mol
VQ-033227
![6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine chemical structure](/media/structures/JNLXKUGLIQPSTA-UHFFFAOYSA-N.svg)
6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine
- CAS
- 1187966-94-4
- Formula
- C20H16FN
- MW
- 289.3 g/mol
VQ-041529
![6-Cyclopropyl-10-fluorobenzo[k]phenanthridine chemical structure](/media/structures/ZZGPBPRQERIOPC-UHFFFAOYSA-N.svg)
Pitavastatin Dihydrobenzophenanthridine Impurity
- CAS
- 1187966-91-1
- Formula
- C25H24FNO4
- MW
- 421.5 g/mol
VQ-033228
Rel-tert-Butyl 2-((4S,6R)-6-((E)-2-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
- CAS
- 167934-29-4
- Formula
- C32H36FNO4
- MW
- 517.63 g/mol
VQ-044499
![tert-Butyl [(4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate chemical structure](/media/structures/TXLXWCARAPIXGH-ZJUUUORDSA-N.svg)
tert-Butyl [(4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate
- CAS
- 154026-94-5
- Formula
- C13H23ClO4
- MW
- 278.77 g/mol
VQ-023512
FAQs — Pitavastatin impurities
Which Pitavastatin impurities do you supply?
We list 40 Pitavastatin-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Pitavastatin impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Pitavastatin impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Pitavastatin impurity standards
We reply within one business day with price, pack options, lead time and documentation.